Nidanilimab (Anti-IL-1RAP / IL-1R3)Nidanilimab (Anti-IL-1RAP / IL-1R3)
Move your mouse over image or click to enlarge

Nidanilimab (Anti-IL-1RAP / IL-1R3)

Nidanilimab (Anti-IL-1RAP / IL-1R3) is a fully humanized monoclonal antibody targeting IL1RAP and blocks IL1α and IL1β signaling. It also stimulates the immune system to destroy tumour cells. It can be used in treatment of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC). MW :143.56 KD.
Cat# Size Price Qty Buy
A2444-1mg*25 1mg*25
£2,432.00
A2444-1mg*5 1mg*5
£794.00
A2444-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2444

Related Documents